# Gilead Sciences Inc
### NASDAQ/NGS:GILD
View full report here!
## Summary
* ETFs holding this stock are seeing positive inflows but are weakening
* Bearish sentiment is low
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for GILD with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GILD.
## Money flow
ETF/Index ownership | Negative
ETF activity is negative and may be weakening. The net inflows of $7.20 billion over the last one-month into ETFs that hold GILD are among the lowest of the last year and appear to be slowing.
## Economic sentiment
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing.
## Credit worthiness
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to score@ihsmarkit.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

Non-alcoholic fatty liver disease, or NAFLD, is a disorder resulting from accumulation of fat in the liver of people who do not consume alcohol. NAFLD is a less serious condition, although non-alcoholic steatohepatitis, or NASH — a subset of NAFLD — is life-threatening, given its potential to cause liver scarring and cirrhosis. NAFLD affects about 80-100 million people in the U.S. alone — roughly 25 percent of the total population.

# Gilead Sciences Inc
### NASDAQ/NGS:GILD
View full report here!
## Summary
* ETFs holding this stock are seeing positive inflows but are weakening
* Bearish sentiment is low
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for GILD with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GILD.
## Money flow
ETF/Index ownership | Neutral
ETF activity is neutral. The net inflows of $9.02 billion over the last one-month into ETFs that hold GILD are not among the highest of the last year and have been slowing.
## Economic sentiment
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing.
## Credit worthiness
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to score@ihsmarkit.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders
Read More...

Making money in the stock market this year is going to take all the skill and luck you can muster. The global economy is slowing, a trade war with China still lingers despite negotiations, and the Federal Reserve remains likely to raise short-term interest rates, albeit slowly.
But you still can find promising investments. To identify some of the top stocks right now, I interviewed Jerome Dodson, manager of Parnassus Endeavor Fund (PARWX) and founder of the Parnassus funds. Based in San Francisco, Parnassus is the largest U.S. fund firm focused on buying good stocks that are also, in the firm's view, good corporate citizens in terms of the environment, social and corporate governance issues.
More to the point, Dodson's fund has a first-class record. Endeavor returned an annualized 16.3% over the past 10 years - an average of 3.1 percentage points per year better than the Standard & Poor's 500-stock index. Dodson, 75, is a contrarian investor who loves to pounce on stocks that have been pummeled.
Given the selloff, this is precisely Dodson's kind of market. Read on for his seven top stocks for 2019.
### SEE ALSO: 19 Best Retirement Stocks to Buy in 2019

# Gilead Sciences Inc
### NASDAQ/NGS:GILD
View full report here!
## Summary
* ETFs holding this stock are seeing positive inflows
* Bearish sentiment is low
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for GILD with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GILD.
## Money flow
ETF/Index ownership | Positive
ETF activity is positive. Over the last month, ETFs holding GILD are favorable, with net inflows of $20.43 billion. Additionally, the rate of inflows is increasing.
## Economic sentiment
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing.
## Credit worthiness
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to score@ihsmarkit.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

It's official. The Nasdaq Composite has waded all the way into bear-market territory, now down 20% from its late-September peak. The Dow Jones Industrial Average and the Standard & Poor's 500-stock index aren't far behind.
Whether the fourth-quarter selloff is merited doesn't entirely matter. If the crowd believes the rout suffered over the course of the past three months is the shape of things to come, stocks will lose more ground as investors create the very bear market they fear. It's a self-fulfilling prophecy.
But here at the precipice of seeing the market's condition shift from bad to worse, remember: Not all stocks have to lose ground, even if the tide is going out. One only has to look at the nine big stocks that managed to gain ground between October 2007 and March 2009 - America's last bear market - to appreciate that some companies have staying power even in rough environments.
Here are nine S&P; 500 stocks that actually gained in the face of the 2007-09 bear market. Notice in all nine cases, there was something unique about these organizations that shielded them from the full impact of economic woe. And in some cases, they still look properly positioned to fight off another bear attack.
### SEE ALSO: 19 Best Stocks to Buy for 2019 (And 5 to Sell)

# Gilead Sciences Inc
### NASDAQ/NGS:GILD
View full report here!
## Summary
* ETFs holding this stock are seeing positive inflows
* Bearish sentiment is low
* Economic output in this company's sector is expanding
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for GILD with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GILD.
## Money flow
ETF/Index ownership | Positive
ETF activity is positive. Over the last month, ETFs holding GILD are favorable, with net inflows of $20.43 billion. Additionally, the rate of inflows is increasing.
## Economic sentiment
PMI by IHS Markit | Positive
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.
## Credit worthiness
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to score@ihsmarkit.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

Gilead Sciences, Inc. (GILD) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Epclusa® (sofosbuvir 400mg/velpatasvir 100mg), a once-daily treatment for adults with chronic hepatitis C virus (HCV) infection with decompensated cirrhosis, and for patients with chronic HCV infection without cirrhosis or with compensated cirrhosis who have had prior treatment with a direct-acting antiviral therapy (DAA).